Next Generation Sequencing Technology in the Clinic and Its Challenges

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• Clinical oncology relies heavily on analyzing next-generation sequencing (NGS) data.
• The rapid advancement of NGS has led to an exponential increase in data volume, necessitating sophisticated analytical tools.
• Diverse bioinformatic tools exist, each with unique characteristics, potentially leading to varied interpretations of the same genomic data.

Purpose of the Study:

• To highlight the importance of evaluating and validating bioinformatics pipelines in clinical settings.
• To discuss the impact of different sequencing technologies and genome complexities on data analysis.
• To address the clinical demand and design considerations for implementing NGS in personalized medicine.

Main Methods:

• Review of various sequencing technologies and their impact on data generation.
• Analysis of bioinformatic tools used for processing and interpreting NGS data.
• Discussion of genomic complexity and its influence on data annotation.

Main Results:

• Different bioinformatic tools can yield diverse outcomes when analyzing the same NGS data.
• The choice of sequencing technology and the complexity of genomic features affect data interpretation.
• There is a critical need for standardized and validated bioinformatics pipelines in clinical practice.

Conclusions:

• Validating bioinformatics pipelines is essential for accurate genomic interpretation in clinical oncology.
• Understanding the nuances of sequencing technologies and bioinformatic tools is vital for personalized medicine.
• Effective implementation of NGS requires careful consideration of clinical demand and pipeline design.